title: Complete Genome Sequence of West Nile Virus Strains Used for the Formulation of CBER/FDA RNA Reference Reagents and Lot Release Panels for Nucleic Acid Testing.
abstract: We report the complete sequences of two West Nile virus strains (FDA-Hu02 and NY99) used for the formulation of CBER/FDA RNA reference reagents and lot release panels for use with nucleic acid technology testing.
authors.affiliation: Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland, USA maria.rios@fda.hhs.gov andriyan.grinev@fda.hhs.gov.
authors.forename: Andriyan
authors.initials: A
authors.lastname: Grinev
authors.affiliation: Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland, USA.
authors.forename: Germán
authors.identifier: http://orcid.org/0000-0001-5361-3001
authors.initials: G
authors.lastname: Añez
authors.affiliation: Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Bethesda, Maryland, USA maria.rios@fda.hhs.gov andriyan.grinev@fda.hhs.gov.
authors.forename: Maria
authors.initials: M
authors.lastname: Rios